CorMatrix ECM Video
Watch how ECM Technology helps repair damaged heart tissue
Clinical Information Overview
Nearly 20,000 implants of CorMatrix ECM™ occurred since the first product was launched in 2006. Preclinical and clinical studies continue to look at new ways the unique CorMatrix ECM may advance the future of cardiovascular medicine. Future clinical studies will support further understanding of the value of CorMatrix ECM in addressing cardiovascular disease.
“We continue to be impressed by the preclinical data we see in the lab and how it compares to real-world usage in the operating room. We are eager to extend our work in heart failure and other cardiovascular diseases from the lab to the clinic and will continue to invest to make a significant impact for patients with cardiovascular disease.”
Robert Matheny, MD
Co-Founder, Chief Scientific Officer
CorMatrix Cardiovascular, Inc.